Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-05

AUTHORS

Alexandra C. McPherron, Ann M. Lawler, Se-Jin Lee

ABSTRACT

The transforming growth factor-β (TGF-β) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals1. Using degenerate polymerase chain reaction, we have identified a new murine TGF-β family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth. More... »

PAGES

83-90

Journal

TITLE

Nature

ISSUE

6628

VOLUME

387

Related Patents

  • Method For Treating Muscle Wasting Syndrome Using Antagonist Antibodies Against Gdf-8
  • Method Of Increasing Muscle Mass By Administering A Myostatin Binding Agent
  • Using Bone Morphogenic Protein Specific Immunoglobulin For Treatment And Prevention Of Osteopenia, Osteomalacia, Osteoporosis, Osteomyeloma, Osteodystrophy And Paget's Disease
  • Mesoporous Silica Compositions Comprising Inflammatory Cytokines Comprising Inflammatory Cytokines For Modulating Immune Responses
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Anti-Activin A Antibodies And Uses Thereof
  • Continuous Cell Programming Devices
  • Injectable, Pore-Forming Hydrogels For Materials-Based Cell Therapies
  • Oligonucleotide Probes; Hybridization; Polynucleotides; Use For Modulating Muscle Cell And Adipose Tissue Growth And Detection Of Cell Proliferative Disorder Of Muscle, Nerve Or Fat Tissues
  • Oligomers
  • Activin Receptor Type Iia Variants And Methods Of Use Thereof
  • Gasp1: A Follistatin Domain Containing Protein
  • Method For Down-Regulating Gdf-8 Activity
  • Injectable Cryogel Vaccine Devices And Methods Of Use Thereof
  • Methods For Increasing Red Blood Cell Levels And Treating Anemia Using A Combination Of Gdf Traps And Erythropoietin Receptor Activators
  • Immunoglobulin Against Growth Differentiation Factor -8 (Gdf-8) For Use In The Prevention And Treatment Of Bone, Muscular, Nervous System And Obesity; Muscle Enhancement
  • Use Of Myostatin Inhibitors And Combination Therapies
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Fc Region Variant
  • Gasp1: A Follistatin Domain Containing Protein
  • Modulate Myostatin Signal Transduction; Obesity
  • Isolated Polynucleotide That Encodes An Actriia-Fc Fusion Polypeptide
  • Method Of Enriching For Pancreatic Endoderm Cells
  • Methods To Identify Growth Differentiation Factor (Gdf) Receptors
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Compositions And Methods For The Treatment Of Muscle Wasting
  • Oligomers
  • Methods Of Increasing Muscle Mass Using Follistatin-Like Related Gene (Flrg)
  • Oligomers
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Modified And Stabilized Gdf Propeptides And Uses Thereof
  • Methods For Increasing Lean Body Mass With Resistance Training And A Gdf8 Inhibitor That Is An Anti-Gdf8 Antibody
  • Controlled Delivery Of Tlr Agonists In Structural Polymeric Devices
  • Therapeutic Methods For Muscular Or Neuromuscular Disorders
  • Antibody To Gdf8 And Uses Thereof
  • Antigen-Binding Molecule Capable Of Binding Two Or More Antigen Molecules Repeatedly
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Antisense-Induced Exon Exclusion In Myostatin
  • Anti-Activin A Antibodies And Uses Thereof
  • Nucleic Acid Sequence Encodes A Polypeptide That Regulates Muscle Cell Growth
  • Methods And Compositions For Improving Skeletal Muscle Protein Fractional Synthetic Rate
  • Scaffolds For Cell Transplantation
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Method For Treating Muscular Dystrophy Using Antagonist Antibodies Against Gdf-8
  • Myostatin Gene Promoter And Inhibition Of Activation Thereof
  • Relate To Various Cell Proliferative Disorders, Especially Those Involving Muscle, Nerve, And Adipose Tissue
  • Activin-Actriia Antagonists For Treating A Follicle-Stimulating Horomone-Secreting Pituitary Tumor
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Polynucleotides Encoding Antagonist Antibodies Against Gdf-8
  • Myostatin Inhibitor Comprising Extracellular Water-Soluble Domains Of Dlk1 As Active Ingredient
  • Methods For Increasing Thermogenic Adipocytes
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Activin Receptor Type Iia Variants And Methods Of Use Thereof
  • Polynucleotides Encoding Myostatin Binding Agents
  • Activin-Actriia Antagonists And Uses For Treating Or Preventing Breast Cancer
  • Methods For Increasing Thermogenic Adipocytes
  • Using Allelic Variation To Differentiate Animal Products On Basis Of Breed Origin
  • For Increasing Muscle Synthesis And Treating Disease In Vertebrate Subjects, For Reducing Myostatin Activity
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Materials Presenting Notch Signaling Molecules To Control Cell Behavior
  • Scaffolds For Cell Transplantation
  • Combination Vaccine Devices And Methods Of Killing Cancer Cells
  • Neutralizing Antibodies Against Gdf-8 And Uses Therefor
  • Isolated Nucleic Acid Molecule Encoding An Antibody That Reduces Gdf-8 Activity
  • Activin-Actrii Antagonists And Uses For Increasing Red Blood Cell Levels
  • Variants Derived From Actriib And Uses Therefor
  • Double-Muscling In Mammals
  • Methods For Enriching For Pancreatic Endocrine Cells
  • Anti-Myostatin Antibodies
  • Scaffolds For Cell Transplantation
  • Compositions And Methods For Increasing Muscle Mass And Muscle Strength By Specifically Antagonizing Gdf8 And Or Activin A
  • Activin-Actriia Antagonists And Uses For Decreasing Or Inhibiting Fsh Secretion
  • Isolated Cell Comprising A Nucleic Acid Encoding Antibody Inhibitors Of Gdf-8 And Uses Thereof
  • Use Of Follistatin To Increase Muscle Mass
  • Isolated Activin-Binding Actriia Polypeptide Comprising The Seq Id No: 7 And Uses For Promoting Bone Growth
  • Growth Differentiation Factor-8
  • Gasp1: A Follistatin Domain Containing Protein
  • Controlled Release Of Growth Factors And Signaling Molecules For Promoting Angiogenesis
  • Proteolytic Fragment Of A Growth Differentiation Factor (Gdf) Polypeptide (Pro-Gdf) Or A Functional Peptide Portion Thereof; Affects Activity Associated With Gdf Signal Transduction
  • Method Of Promoting Bone Growth By An Anti-Activin B Antibody
  • Anti-Myostatin Antibodies
  • Compositions And Methods For Identifying And Testing Tgf-Β Pathway Agonists And Antagonists
  • Administering Inhibitors Of Tgfbeta Signaling, Benzothiazepine Derivatives Or Combinations Thereof To Improve Muscle Function In Cancer Patients
  • Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Methods And Compositions For Improving Skeletal Muscle Protein Fractional Synthetic Rate
  • Activin-Actriia Antagonists And Uses For Treating Multiple Myeloma
  • Growth Differentiation Factor-8 Nucleic Acid And Polypeptide From Aquatic Species, And Transgenic Aquatic Species
  • Enhancement Of Skeletal Muscle Stem Cell Engraftment By Dual Delivery Of Vegf And Igf-1
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Growth Differentiation Factor-8 Nucleic Acid And Polypeptides From Aquatic Species And Non-Human Transgenic Aquatic Species
  • Method Of Enriching For Pancreatic Endocrine Cells That Express Chromogranin A
  • Programming Of Cells For Tolerogenic Therapies
  • Isolated Nucleic Acid Encoding A Truncated Actriib Fusion Protein
  • Actriib Proteins And Variants And Uses Therefore Relating To Utrophin Induction For Muscular Dystrophy Therapy
  • Use Of Myostatin Inhibitors And Combination Therapies
  • Use Of Decorin For Increasing Muscle Mass
  • Mesoporous Silica Compositions For Modulating Immune Responses
  • Uses Of Growth And Differentiation Factor 8 (Gdf-8)
  • Polypeptides; Proteolysis Splitting; Antitumor Agents
  • Controlled Release Of Growth Factors And Signaling Molecules For Promoting Angiogenesis
  • Increasing The Muscle Mass In An Animal By Administering An Antibody, Or Antigen-Binding Fragment Of Said Antibody, Which Binds To And Inhibits The Activity Of Gdf-8 Polypeptide
  • Growth Differentiation Factor-8
  • Methods For Screening Compounds For Increasing Thermogenic Adipocytes
  • Activin-Actriia Antagonists And Uses For Promoting Bone Growth
  • Injectable Preformed Macroscopic 3-Dimensional Scaffolds For Minimally Invasive Administration
  • Method For Predicting Athletic Performance Potential
  • Plant Virus Coat Fusion Proteins With Gdf8 Epitopes And Vaccines Thereof
  • Growth Differentiation Factor-8 Nucleic Acid And Polypeptides From Aquatic Species And Non-Human Transgenic Aquatic Species
  • Co-Delivery Of Stimulatory And Inhibitory Factors To Create Temporally Stable And Spatially Restricted Zones
  • Scaffolds For Cell Transplantation
  • For Modulating Growth Of A Tissue, Such As Bone, Cartilage, Muscle, Fat, And/Or Neuron; Comprising An Altered Growth Differentiation Factor 11 (Gdf11)-Binding Domain Of An Actrii Receptor
  • Myostatin Irna Compositions And Methods Of Use Thereof
  • Method Of Enriching For Pancreatic Endocrine Cells That Express Chromogranin A
  • Programming Of Cells For Tolerogenic Therapies
  • Polypeptide Comprises Amino Acid Sequences Having Point Mutations Of Cleavage Sites For Metalloenzymes, Used For Prophylaxis Of Metabolic And Muscular Disorders; Bone Morphogenetic Protein/Tolloid Or Tolloid-Like Protein Complexes
  • Method For Producing An Actriib-Fc Fusion Polypeptide
  • Methods For Purifying Endoderm And Pancreatic Endoderm Cells Derived From Human Embryonic Stem Cells
  • Methods For Controlling Blood Pharmacokinetics Of Antibodies
  • Methods Of Identifying Actriib Variants
  • Casting Process And Sand Mould Provided With An Inlet System For Producing At Least Partly Thin Walled Aluminium Casts With Sand Moulding Technology By Means Of Gravity Casting
  • Follistatin Domain Containing Proteins
  • Multi-Arm Polymeric Prodrug Conjugates Of Taxane-Based Compounds
  • Antagonist Antibodies Against Gdf-8
  • Scaffolds For Cell Transplantation
  • Enhancement Of Skeletal Muscle Stem Cell Engraftment By Dual Delivery Of Vegf And Igf-1
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Use Of Myostatin Inhibitors And Combination Therapies
  • Programming Of Cells For Tolerogenic Therapies
  • Method Of Increasing Red Blood Cell Levels Or Treating Anemia In A Patient
  • Isolated Gdf Trap Polypeptide
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Isolated Nucleic Acid Encoding A Truncated Actriib Fusion Protein
  • Actriib Proteins And Variants And Uses Therefore Relating To Utrophin Induction For Muscular Dystrophy Therapy
  • Modified And Stabilized Gdf Propeptides And Uses Thereof
  • Growth Differentiation Factor-8
  • Methods Of Increasing Sarcolemmal Utrophin
  • Use Of Gdf Traps To Treat Anemia
  • Modified And Stabilized Gdf Propeptides And Uses Thereof
  • Guided Injections For Aav Gene Transfer To Muscle
  • Activin-Actrii Antagonists And Uses For Increasing Red Blood Cell Levels
  • Fcgammariib-Specific Fc Region Variant
  • Controlled Delivery Of Tlr3 Agonists In Structural Polymeric Devices
  • Methods Of Promoting Fat Loss Comprising Administering An Alk7 Inhibitor
  • Methods For Treating Ulcers In Thalassemia Syndrome With An Actriib Polypeptide
  • Actriib Proteins And Variants And Uses Therefore Relating To Utrophin Induction For Muscular Dystrophy Therapy
  • Neutralizing Antibodies Against Gdf-8 And Uses Therefor
  • Continuous Cell Programming Devices
  • Methods For Increasing Adiponectin In A Patient In Need Thereof
  • Moderate Cell Differentiation; Muscular Disorders; Fat Metabolism; Bone Disorders
  • In Situ Antigen-Generating Cancer Vaccine
  • Method Of Promoting Bone Growth By An Anti-Activin A Antibody
  • Method Of Identifying An Agent That Promotes Bone Growth Or Increases Bone Density
  • Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
  • Antibody To Gdf8 And Uses Thereof
  • Antigen-Binding Molecule Capable Of Binding Two Or More Antigen Molecules Repeatedly
  • Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
  • Scaffolds For Cell Transplantation
  • Binding Agents Which Inhibit Myostatin
  • Methods For Increasing Thermogenic Adipocytes
  • Scaffolds For Cell Collection Or Elimination
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Activin-Actriia Antagonists And Uses For Treating Multiple Myeloma
  • Method For Treating Il-8-Related Diseases
  • Multi-Arm Polymeric Alkanoate Conjugates
  • A Nucleic Acid Molecule; Treatment Of Muscle Wasting Caused From Aging, Autoimmune Deficiency Syndrome, Multiple Sclerosis And Cancer
  • Method Of Eliciting An Anti-Tumor Immune Response With Controlled Delivery Of Tlr Agonists In Porous Polymerlc Devices
  • Antigenic Peptide Fragments Of Growth Differentiation Factor 8, And Related Immunogens, Vaccines; Immunization; Drug Screening
  • Activin-Actriia Antagonists For Inhibiting Germ Cell Maturation
  • Neutralizing Gdf8 Epitope-Based Growth Enhancing Vaccine
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Antisense Composition And Method For Treating Muscle Atrophy
  • Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
  • Muscle Regeneration
  • Having High Affinity And May Be Chimeric, Humanized Or Fully Human Antibodies, Immunoconjugates Of The Antibodies Or Antigen-Binding Fragments Thereof; Useful For Increasing Muscle Mass, Increasing Bone Density, Or For The Treatment Of Various Disorders In Mammalian And Avian Species
  • Double-Muscling In Mammals
  • Programming Of Cells For Tolerogenic Therapies
  • Methods For Altering Body Composition By Administering A Gdf8 Inhibitor And An Activin A Inhibitor
  • Polynucleotides Encoding Promyostatin Polypeptides
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Mouse Fcγammarii-Specific Fc Antibody
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Use Of Decorin For Increasing Muscle Mass
  • Nucleic Acids Encoding Neutralizing Gdf8 Epitope-Based Peptides And Fusion Proteins
  • Having High Affinity And May Be Chimeric, Humanized Or Fully Human Antibodies, Immunoconjugates Of The Antibodies Or Antigen-Binding Fragments Thereof; Useful For Increasing Muscle Mass, Increasing Bone Density, Or For The Treatment Of Various Disorders In Mammalian And Avian Species
  • Follistatin Variant Polypeptide
  • Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
  • Transgenic Non-Human Animals Expressing A Truncated Activin Type Ii Receptor
  • Methods Of Treating Musculodegenerative Disease With An Antibody That Binds Growth Differentiation Factor-8
  • Anti-Myostatin Antibodies
  • Increasing Muscle Mass While Reducing Fat And Cholesterol Levels In Animal Food Products
  • Variants Derived From Actriib And Uses Therefor
  • Growth Differentiation Factor-8
  • Antagonist Antibodies Against Gdf-8 And Uses Therefor
  • Antibodies Against Growth And Differentiation Factor-8 (Gdf-8), Also Known As Myostatin, Including Fragments; Muscle And Bone Degenerative Disorders; Muscular Dystropy/Atrophy; Antidiabetic Agents; Congestive Obstructive Pulmonary Disease
  • Growth Differentiation Factor-8 Nucleic Acid And Polypeptide From Aquatic Species, And Transgenic Aquatic Species
  • Method For Decreasing The Body Fat Content In A Subject By Administering An Actriib Protein
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Scaffolds For Cell Collection Or Elimination
  • Method For Decreasing The Body Fat Content In A Subject By Administering An Actriib Protein
  • Actriia Binding Agents And Uses Thereof
  • Methods Of Promoting Fat Loss Comprising Administering An Alk7 Inhibitor
  • Growth Differentiation Factor-8
  • Methods And Compositions For Reducing Serum Lipids
  • Methods And Compositions For Treating Ulcers
  • Antagonist Antibodies Against Gdf-8 And Uses Therefor
  • Neutralizing Antibodies Against Gdf-8 And Uses Therefor
  • Truncated Actriib-Fc Fusion Protein
  • Myostatin Inhibition For Enhancing Muscle And/Or Improving Muscle Function
  • Antibody To Gdf8 And Uses Thereof
  • Oligomers
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Multi-Arm Polymeric Prodrug Conjugates Of Cabazitaxel-Based Compounds
  • Variants Derived From Actriib
  • Anti-Myostatin Antibodies
  • Increasing Muscle Mass While Reducing Fat And Cholesterol Levels In Animal Food Products
  • Antibodies To Human Gdf8
  • Nucleic Acids Encoding Neutralizing Gdf8 Epitope-Based Peptides And Fusion Proteins
  • Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
  • Mouse Fcγammarii-Specific Fc Antibody
  • Having High Affinity And May Be Chimeric, Humanized Or Fully Human Antibodies, Immunoconjugates Of The Antibodies Or Antigen-Binding Fragments Thereof; Useful For Increasing Muscle Mass, Increasing Bone Density, Or For The Treatment Of Various Disorders In Mammalian And Avian Species
  • Follistatin Variant Polypeptide
  • Transgenic Non-Human Animals Expressing A Truncated Activin Type Ii Receptor
  • Methods Of Treating Musculodegenerative Disease With An Antibody That Binds Growth Differentiation Factor-8
  • Harnessing Cell Dynamics To Engineer Materials
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/387083a0

    DOI

    http://dx.doi.org/10.1038/387083a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1027453384

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9139826


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aging", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amino Acid Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Body Weight", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "CHO Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cloning, Molecular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cricetinae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Embryo, Mammalian", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Targeting", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Homozygote", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hyperplasia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hypertrophy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "In Situ Hybridization", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred C57BL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Muscle, Skeletal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myostatin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polymerase Chain Reaction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Sorting Signals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transforming Growth Factor beta", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McPherron", 
            "givenName": "Alexandra C.", 
            "id": "sg:person.01317615613.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317615613.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lawler", 
            "givenName": "Ann M.", 
            "id": "sg:person.0612727554.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612727554.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Se-Jin", 
            "id": "sg:person.0642324713.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642324713.59"
            ], 
            "type": "Person"
          }
        ], 
        "datePublished": "1997-05", 
        "datePublishedReg": "1997-05-01", 
        "description": "The transforming growth factor-\u03b2 (TGF-\u03b2) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals1. Using degenerate polymerase chain reaction, we have identified a new murine TGF-\u03b2 family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/387083a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6628", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "387"
          }
        ], 
        "keywords": [
          "Growth/differentiation factor 8", 
          "wild-type animals", 
          "TGF-\u03b2 family members", 
          "degenerate polymerase chain reaction", 
          "adult skeletal muscle", 
          "skeletal muscle growth", 
          "GDF-8 expression", 
          "differentiation factor 8", 
          "embryonic development", 
          "tissue homeostasis", 
          "mutant animals", 
          "superfamily members", 
          "biological functions", 
          "negative regulator", 
          "null animals", 
          "muscle growth", 
          "skeletal muscle mass", 
          "factor 8", 
          "differentiation factor", 
          "genes", 
          "skeletal muscle", 
          "growth factor", 
          "muscle cell hyperplasia", 
          "polymerase chain reaction", 
          "family members", 
          "adult animals", 
          "muscle mass", 
          "important role", 
          "later stages", 
          "embryogenesis", 
          "animals", 
          "somites", 
          "chain reaction", 
          "regulator", 
          "growth", 
          "members", 
          "homeostasis", 
          "large group", 
          "regulation", 
          "widespread increase", 
          "mice", 
          "expression", 
          "compartments", 
          "early stages", 
          "animals1", 
          "muscle", 
          "function", 
          "stage", 
          "different muscles", 
          "role", 
          "factors", 
          "mass", 
          "increase", 
          "development", 
          "individual muscles", 
          "cell hyperplasia", 
          "body", 
          "hypertrophy", 
          "combination", 
          "results", 
          "group", 
          "reaction", 
          "time", 
          "hyperplasia"
        ], 
        "name": "Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member", 
        "pagination": "83-90", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1027453384"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/387083a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9139826"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/387083a0", 
          "https://app.dimensions.ai/details/publication/pub.1027453384"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:30", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_296.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/387083a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/387083a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/387083a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/387083a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/387083a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    233 TRIPLES      20 PREDICATES      113 URIs      105 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/387083a0 schema:about N0df4f127ddd94d9ca26777405ad18105
    2 N135c7fde885d4cd5846341926d8fb7ad
    3 N18d4957e39a94b46bb0a538d27b7d31b
    4 N347e10b50aba469d90269fdfccf8f0c2
    5 N361f107bc3fa427b8c7181f458e02e7f
    6 N441ab2b4a1094cc79f37ea0e34a85840
    7 N53bc2c346a5c43d9aa9e6a7fdf3ed39c
    8 N573cba4c7cb742c88b7dd5e95d64cf9d
    9 N58936bda20fd48299291e826d33b1d57
    10 N67c69873028b46ddbd111638af963771
    11 N86e7fd00beb149c7a0cb7454a82c7948
    12 N8ec838da18ed47bdb61829cf1e26ca92
    13 N9a60208eaad649e38a61d9a21333664e
    14 Na1fadbdb1fd8457697801824e7a4db4d
    15 Na4f33093da3a46a0b6efda9e1c1d0539
    16 Nb33430ec95394d47979b1bea3c7bd14a
    17 Ncaf1059374d04b73bd02ef088c1c89f9
    18 Ncca8e1ffd74d4b949dee56853a7e1ee9
    19 Nd96d09a8fbfe44289230d8f4723d07d5
    20 Nde590417aa384be3b387d099212fb525
    21 Nfb41d8e5265942eeb8c2b9b92b9502bb
    22 Nfdc45f1436ae4d80b9f1955592e3e569
    23 Nfef3a4297c79456fb7e3dfab0af91746
    24 anzsrc-for:06
    25 anzsrc-for:0604
    26 schema:author Nde7a2cdaab8f43738b5c5d8a8d19e33f
    27 schema:datePublished 1997-05
    28 schema:datePublishedReg 1997-05-01
    29 schema:description The transforming growth factor-β (TGF-β) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals1. Using degenerate polymerase chain reaction, we have identified a new murine TGF-β family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth.
    30 schema:genre article
    31 schema:isAccessibleForFree false
    32 schema:isPartOf Nb2037232268b46249afbe448ea622466
    33 Nc47004a7bacb49d99e37eff7a29f1ec7
    34 sg:journal.1018957
    35 schema:keywords GDF-8 expression
    36 Growth/differentiation factor 8
    37 TGF-β family members
    38 adult animals
    39 adult skeletal muscle
    40 animals
    41 animals1
    42 biological functions
    43 body
    44 cell hyperplasia
    45 chain reaction
    46 combination
    47 compartments
    48 degenerate polymerase chain reaction
    49 development
    50 different muscles
    51 differentiation factor
    52 differentiation factor 8
    53 early stages
    54 embryogenesis
    55 embryonic development
    56 expression
    57 factor 8
    58 factors
    59 family members
    60 function
    61 genes
    62 group
    63 growth
    64 growth factor
    65 homeostasis
    66 hyperplasia
    67 hypertrophy
    68 important role
    69 increase
    70 individual muscles
    71 large group
    72 later stages
    73 mass
    74 members
    75 mice
    76 muscle
    77 muscle cell hyperplasia
    78 muscle growth
    79 muscle mass
    80 mutant animals
    81 negative regulator
    82 null animals
    83 polymerase chain reaction
    84 reaction
    85 regulation
    86 regulator
    87 results
    88 role
    89 skeletal muscle
    90 skeletal muscle growth
    91 skeletal muscle mass
    92 somites
    93 stage
    94 superfamily members
    95 time
    96 tissue homeostasis
    97 widespread increase
    98 wild-type animals
    99 schema:name Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
    100 schema:pagination 83-90
    101 schema:productId N0cc4131521c84efba29678c4bcb14e9b
    102 N45d482dce01a41ca964d83e3ec1978c0
    103 Ne21b44c2a2a3413995d9edbd03549dca
    104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027453384
    105 https://doi.org/10.1038/387083a0
    106 schema:sdDatePublished 2022-10-01T06:30
    107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    108 schema:sdPublisher N5f3d1001e1e948a78a63795e801e7270
    109 schema:url https://doi.org/10.1038/387083a0
    110 sgo:license sg:explorer/license/
    111 sgo:sdDataset articles
    112 rdf:type schema:ScholarlyArticle
    113 N0cc4131521c84efba29678c4bcb14e9b schema:name doi
    114 schema:value 10.1038/387083a0
    115 rdf:type schema:PropertyValue
    116 N0df4f127ddd94d9ca26777405ad18105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Body Weight
    118 rdf:type schema:DefinedTerm
    119 N135c7fde885d4cd5846341926d8fb7ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Cricetinae
    121 rdf:type schema:DefinedTerm
    122 N18d4957e39a94b46bb0a538d27b7d31b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Cloning, Molecular
    124 rdf:type schema:DefinedTerm
    125 N347e10b50aba469d90269fdfccf8f0c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Hypertrophy
    127 rdf:type schema:DefinedTerm
    128 N361f107bc3fa427b8c7181f458e02e7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Animals
    130 rdf:type schema:DefinedTerm
    131 N441ab2b4a1094cc79f37ea0e34a85840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Molecular Sequence Data
    133 rdf:type schema:DefinedTerm
    134 N45d482dce01a41ca964d83e3ec1978c0 schema:name pubmed_id
    135 schema:value 9139826
    136 rdf:type schema:PropertyValue
    137 N53bc2c346a5c43d9aa9e6a7fdf3ed39c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Amino Acid Sequence
    139 rdf:type schema:DefinedTerm
    140 N573cba4c7cb742c88b7dd5e95d64cf9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name CHO Cells
    142 rdf:type schema:DefinedTerm
    143 N58936bda20fd48299291e826d33b1d57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Embryo, Mammalian
    145 rdf:type schema:DefinedTerm
    146 N5f3d1001e1e948a78a63795e801e7270 schema:name Springer Nature - SN SciGraph project
    147 rdf:type schema:Organization
    148 N67c69873028b46ddbd111638af963771 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Mice
    150 rdf:type schema:DefinedTerm
    151 N86e7fd00beb149c7a0cb7454a82c7948 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Gene Targeting
    153 rdf:type schema:DefinedTerm
    154 N8e701c018a0a41cfac7e4a454653ae7f rdf:first sg:person.0642324713.59
    155 rdf:rest rdf:nil
    156 N8ec838da18ed47bdb61829cf1e26ca92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Muscle, Skeletal
    158 rdf:type schema:DefinedTerm
    159 N9a60208eaad649e38a61d9a21333664e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Protein Sorting Signals
    161 rdf:type schema:DefinedTerm
    162 Na1fadbdb1fd8457697801824e7a4db4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Humans
    164 rdf:type schema:DefinedTerm
    165 Na4f33093da3a46a0b6efda9e1c1d0539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Mice, Inbred C57BL
    167 rdf:type schema:DefinedTerm
    168 Nb2037232268b46249afbe448ea622466 schema:issueNumber 6628
    169 rdf:type schema:PublicationIssue
    170 Nb33430ec95394d47979b1bea3c7bd14a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Hyperplasia
    172 rdf:type schema:DefinedTerm
    173 Nb9f233826107480eac28c3bd3d5cbb8a rdf:first sg:person.0612727554.84
    174 rdf:rest N8e701c018a0a41cfac7e4a454653ae7f
    175 Nc47004a7bacb49d99e37eff7a29f1ec7 schema:volumeNumber 387
    176 rdf:type schema:PublicationVolume
    177 Ncaf1059374d04b73bd02ef088c1c89f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Stem Cells
    179 rdf:type schema:DefinedTerm
    180 Ncca8e1ffd74d4b949dee56853a7e1ee9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Aging
    182 rdf:type schema:DefinedTerm
    183 Nd96d09a8fbfe44289230d8f4723d07d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Transforming Growth Factor beta
    185 rdf:type schema:DefinedTerm
    186 Nde590417aa384be3b387d099212fb525 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Polymerase Chain Reaction
    188 rdf:type schema:DefinedTerm
    189 Nde7a2cdaab8f43738b5c5d8a8d19e33f rdf:first sg:person.01317615613.98
    190 rdf:rest Nb9f233826107480eac28c3bd3d5cbb8a
    191 Ne21b44c2a2a3413995d9edbd03549dca schema:name dimensions_id
    192 schema:value pub.1027453384
    193 rdf:type schema:PropertyValue
    194 Nfb41d8e5265942eeb8c2b9b92b9502bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name In Situ Hybridization
    196 rdf:type schema:DefinedTerm
    197 Nfdc45f1436ae4d80b9f1955592e3e569 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Myostatin
    199 rdf:type schema:DefinedTerm
    200 Nfef3a4297c79456fb7e3dfab0af91746 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Homozygote
    202 rdf:type schema:DefinedTerm
    203 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    204 schema:name Biological Sciences
    205 rdf:type schema:DefinedTerm
    206 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    207 schema:name Genetics
    208 rdf:type schema:DefinedTerm
    209 sg:journal.1018957 schema:issn 0028-0836
    210 1476-4687
    211 schema:name Nature
    212 schema:publisher Springer Nature
    213 rdf:type schema:Periodical
    214 sg:person.01317615613.98 schema:affiliation grid-institutes:grid.21107.35
    215 schema:familyName McPherron
    216 schema:givenName Alexandra C.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317615613.98
    218 rdf:type schema:Person
    219 sg:person.0612727554.84 schema:affiliation grid-institutes:grid.21107.35
    220 schema:familyName Lawler
    221 schema:givenName Ann M.
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612727554.84
    223 rdf:type schema:Person
    224 sg:person.0642324713.59 schema:affiliation grid-institutes:grid.21107.35
    225 schema:familyName Lee
    226 schema:givenName Se-Jin
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642324713.59
    228 rdf:type schema:Person
    229 grid-institutes:grid.21107.35 schema:alternateName Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    230 Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    231 schema:name Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    232 Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 21205, Baltimore, Maryland, USA
    233 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...